Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of UVB Phototherapy With Microneedling and Circled Needing in Vitiligo Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03718962
Recruitment Status : Recruiting
First Posted : October 25, 2018
Last Update Posted : April 30, 2019
Sponsor:
Information provided by (Responsible Party):
Shin Kong Wu Ho-Su Memorial Hospital

Brief Summary:

Vitiligo is a relatively common acquired disorder of pigmentation characterized by the development of well-defined white macules on the skin. Biopsies of lesional skin reveal a loss of epidermal melanocytes. Lesions may occur in a localized or generalized distribution and may coalesce into large, depigmented areas. Given the contrast between the white areas and normal skin, the disease is most disfiguring in darker skin types and has a profound impact on the quality of life of both children and adults . Patients with vitiligo often experience stigmatization, social isolation, and low self-esteem. The therapys include topical steroids, topical immunosuppresant, systemic steroids, phototherapy, and surgery.

The aim of this study is to investigate the effect of phototherpy and accupuncture combined therapy for vitiligo patients.


Condition or disease Intervention/treatment Phase
Brief Description of Focus of Study Instead Device: accupuncture Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Effect of UVB Phototherapy With Microneedling and Circled Needing in Vitiligo Patients
Actual Study Start Date : October 30, 2018
Estimated Primary Completion Date : October 20, 2019
Estimated Study Completion Date : December 30, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Vitiligo

Arm Intervention/treatment
Experimental: needling patients Device: accupuncture
needling




Primary Outcome Measures :
  1. repigmentation [ Time Frame: 12weeks ]
    repigmentation amount



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Clinical diagnosis of Vitiligo

Exclusion Criteria:

  • pregnancy
  • immune disorder
  • infection
  • other dermatosis in treating areas

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03718962


Contacts
Layout table for location contacts
Contact: Gong Yau Chu, MD 886 987057172 aguest122@hotmail.com.tw

Locations
Layout table for location information
Taiwan
ShinKongHospital Recruiting
Taipei, Taiwan
Contact: Gong Yau Chu, MD    886 987057172    aguest122@hotmail.com.tw   
Principal Investigator: Gong Yau Chu, MD         
Sponsors and Collaborators
Shin Kong Wu Ho-Su Memorial Hospital

Layout table for additonal information
Responsible Party: Shin Kong Wu Ho-Su Memorial Hospital
ClinicalTrials.gov Identifier: NCT03718962     History of Changes
Other Study ID Numbers: 20180205R
First Posted: October 25, 2018    Key Record Dates
Last Update Posted: April 30, 2019
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Vitiligo
Hypopigmentation
Pigmentation Disorders
Skin Diseases